Valuation: Radnostix, Inc.

Market Cap 31.22M 26.76M 25.03M 22.88M 43.18M 2.99B 43.64M 296M 115M 1.5B 117M 115M 4.97B P/E 2024
2,150x
P/E 2025 -35.5x
Enterprise Value 38.43M 32.93M 30.81M 28.17M 53.15M 3.68B 53.72M 365M 142M 1.85B 144M 141M 6.11B EV / Sales 2024
1.76x
EV / Sales 2025 3.03x
Free-Float
26.54%
Yield 2024 *
-
Yield 2025 -
1 day-11.68%
1 week-12.59%
Current month-15.59%
1 month+2.61%
3 months-19.29%
6 months-24.55%
Current year-3.67%
1 week 0.05
Extreme 0.0513
0.07
1 month 0.05
Extreme 0.0465
0.07
Current year 0.05
Extreme 0.0453
0.1
1 year 0.05
Extreme 0.0453
0.11
3 years 0.02
Extreme 0.02
0.11
5 years 0.02
Extreme 0.02
0.12
10 years 0
Extreme 0
0.34
Manager TitleAgeSince
Chief Executive Officer 42 01/09/2023
Director of Finance/CFO 42 30/09/2019
General Counsel 61 01/01/2001
Director TitleAgeSince
Director/Board Member 69 01/06/2001
Chairman 58 01/07/2017
Director/Board Member 74 02/08/2017
Date Insider Type Main position Quantity % Market Cap.
10/10/25 A Free

Director

250,000 0.0478%
10/10/25 A Free

Chairman

500,000 0.0955%
10/10/25 A Free

Director

500,000 0.0955%
Change 5-day change 1-year change 3-year change Capi.($)
-11.68%-12.59%-33.63%-1.67% 35.35M
-0.43%-1.57%-13.63%-30.43% 2.54B
-3.51%-0.28%-10.34%-84.37% 1.98B
+2.48%+0.51%-14.57%-0.20% 353M
+1.82%-5.49%-48.27% - 50.77M
Average -2.26%-0.14%-24.09%-29.17% 992.54M
Weighted average by Cap. -1.51%-0.85%-12.88%-49.85%

Financials

2024 2025
Net sales 13.9M 11.91M 11.14M 10.19M 19.23M 1.33B 19.43M 132M 51.27M 668M 52.19M 51.06M 2.21B 13.07M 11.2M 10.48M 9.58M 18.08M 1.25B 18.27M 124M 48.22M 628M 49.08M 48.01M 2.08B
Net income 8.57K 7.35K 6.87K 6.28K 11.86K 821K 11.99K 81.34K 31.63K 412K 32.19K 31.5K 1.36M -908K -778K -728K -666K -1.26M -86.94M -1.27M -8.61M -3.35M -43.66M -3.41M -3.34M -144M
Net Debt 6.42M 5.5M 5.14M 4.7M 8.87M 614M 8.97M 60.87M 23.67M 309M 24.09M 23.57M 1.02B 7.21M 6.18M 5.78M 5.28M 9.97M 690M 10.07M 68.36M 26.58M 346M 27.06M 26.47M 1.15B
Logo Radnostix, Inc.
Radnostix, Inc., formerly International Isotopes Inc., manufactures a wide range of radioisotope-focused products. The Company manufactures and supplies generic sodium iodide I-131 radio-pharmaceutical drug product for hyperthyroidism and thyroid cancer. The Company provides contract manufacturing of various drug products as well as radioisotope active pharmaceutical ingredient (API) supply for third party theranostics clients. The Company manufactures and distributes a complete line of calibration and reference standards for nuclear pharmacies and single photon emission computed tomography (SPECT)/positron emission tomography (PET) imaging systems as well as industrial calibration standards under its RadQual brand. The Company also manufactures Cobalt-60 sealed source products.
Employees
45
Date Price Change Volume
24/08/26 $0.0590 -11.68% 167,348
21/08/26 $0.0668 +4.37% 300
20/08/26 $0.0640 +14.29% 44,897
19/08/26 $0.0560 -11.53% 47,307
  1. Stock Market
  2. Stocks
  3. INIS Stock